EIF2AK2 and cancer: Many of them achieve cancer specificity by virtue of attenuation, frequently obtained through the deletion of the γ134.5 gene, whose product counteracts the interferon (IFN) and protein kinase R (PKR) response of the cell to the virus (7, –, 10).